Impact of the new clinical breaking points proposed by the clinical and laboratory standards institute (CLSI) in the antifungal susceptibility profile of clinical strains isolated from invasive bloodstream Candida spp. infections in Spain

  1. Cisterna, R.
  2. Tellería, O.
  3. Hernaez, S.
  4. Ezpeleta, G.
Revue:
Clinical Medicine Insights: Therapeutics

ISSN: 1179-559X 1179-559X

Année de publication: 2012

Volumen: 4

Pages: 19-27

Type: Article

DOI: 10.4137/CMT.S8293 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable